Radiculopathy is produced by the pinching of a nerve root in the
spinal column. The problem occurs near a specific nerve; however, pain
and associated symptoms usually appear in the part of the body where
that specific nerve is supplied. For example, a nerve impingement in the
lumbar region can be manifested with symptoms in the foot. Similarly,
an impingement in the cervical spine could result in pain and associated
symptoms in the forearm. The most common symptoms include pain (known
as radicular pain), numbness or parasthesia, weakness in limbs, and
difficulty in controlling specific muscles. It can develop at any age;
however, most of radiculopathy cases have been recorded in people aged
between 45 and 64. Women are at higher risk of developing radiculopathy
than men. People suffering from degenerative diseases, any kind of
infection, diabetes, or who are engaged in heavy lifting or high-impact
sports or suffering from the conditions such as spurs, disc herniation,
or scoliosis are at higher risk of developing radiculopathy.
The global radiculopathy market can be segmented based on type,
treatment, and region. In terms of type, the global market can be
categorized into lumbar radiculopathy (affects lower neck), cervical
radiculopathy (compressed nerve root in the neck), and thoracic
radiculopathy (compressed nerve root in the thoracic area of the spine).
The lumbar radiculopathy segment is expected to be driven by high
incidence rate. In terms of treatment, the global radiculopathy market
can be classified into conservative treatment, epidural steroid
injection, and surgical treatment. Conservative treatment includes
medicines such as non-steroidal anti-inflammatory drugs, opioid
medicines, and muscle relaxants. Conservative treatment is used to
manage pain, muscle spasm, inflammation, and sleep disturbance. Cervical
posterior foraminotomy is commonly performed surgery for radiculopathy;
however, other surgeries are also available. Rise in incidence and
prevalence rates of radiculopathy, increased research and development
expenditure, surge in awareness among people are likely to contribute to
the growth of the global radiculopathy market during the forecast
period. However, poor patient awareness and increase in use of home
remedies hamper the growth of the market.
Geographically, the global radiculopathy market can be segmented into
five major regions: North America, Europe, Latin America, Asia Pacific,
and Middle East & Africa. North America is anticipated to dominate
the global market, followed by Europe. An estimated 3% to 5% of the
population of the U.S. is affected by radiculopathy. Hence, increase in
incidence rate boosts the growth of the market in North America.
Additionally, growing awareness among people, increase in research and
development expenditure, and well-established health care infrastructure
fuel the growth of the radiculopathy market in North America. The
market in Asia Pacific is anticipated to expand at a high CAGR during
the forecast period. The market is driven by large population base,
increased government initiatives, and developing health care
infrastructure in India and China. The market in Latin America and
Middle East & Africa is anticipated to be driven by increase in
investments by key players and rise in prevalence of radiculopathy.
Leading players in the global radiculopathy market include DePuy Synthes, Inc. (Johnson & Johnson Company), Bayer AG, and Biogen Idec.
Report Overview @ https://www.transparencymarketresearch.com/radiculopathy-market.html
Leading players in the global radiculopathy market include DePuy Synthes, Inc. (Johnson & Johnson Company), Bayer AG, and Biogen Idec.
No comments:
Post a Comment